Head Pain
Conditions
Keywords
intavenous, magnesium sulfate, nontraumatic, acute headaches, placebo
Brief summary
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Detailed description
Rate of Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Interventions
magnesium group 1g paracetamol + 20 min infusion of 2 g magnesium in 150 ml of saline serum and Placebo Group 1g paracetamol + 20 min infusion of 150 ml of saline serum
Sponsors
Study design
Eligibility
Inclusion criteria
* informed consent * age \>18 years * Acute non-traumatic acute headaches * patients treated in ED * Magnesium sulfate and aspirin administered intravenously (IV)
Exclusion criteria
* Current regular use of analgesics, anticonvulsants or antidepressants * Renal disorder with a low glomerular filtration rate (\<60 ml/min) * Neuromuscular disorder * Pregnant woman * Contrindication * Allergy to NSAID * Traumatic Headache * Chronic headache ( headache occurring at least 15 days per month for at least 3 months) * Hemodynamic instability
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Intravenous Magnesium Sulfate to Treat Non -Traumatic Acute Headaches in the Emergency Department | 1day | Patients with Non -Traumatic Acute Headaches in the Emergency Department recived 1g paracetamol + 20 min infusion of 2g magnesium |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department | 1 day | Patients with Non -Traumatic Acute Headaches in the Emergency Department received 1g paracetamol + 20 min infusion of saline serum |
Countries
Tunisia